Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2025-12-25 @ 2:35 AM
NCT ID:
NCT02151734
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients aged 12-75 years old
* A total score of BSS ≥ 5
* The duration of symptoms had to be less than 14 days and no chronic pulmonary disease
* Patients who voluntarily sign a written informed consent to participate in the trial
Exclusion Criteria:
* Indication for antibiotic treatment(e.g. severe respiratory infection)
* Allergic bronchial asthma
* Tendency to bleed
* Severe heart, renal, or liver diseases or decline of immune function
* Chronic obstructive pulmonary disease
* Known or supposed hypersensitivity to investigational medication
* Treatment with antibiotics during the past 4 weeks prior to inclusion in the trial
* Women during pregnancy or lactation period
* Clinically significant abnormal values in the screening test(more than twice the upper limit of normal range for ALT, AST, BUN, and Serum Creatinine)
* Participation in any other trial within 30 days prior to inclusion in the trial
* Unsuitable patients for enrollment in the opinion of the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
75 Years
Study:
NCT02151734
Study Brief:
Protocol Section:
NCT02151734